InvestorsHub Logo
Followers 10
Posts 1249
Boards Moderated 0
Alias Born 07/20/2020

Re: None

Monday, 12/05/2022 11:08:46 AM

Monday, December 05, 2022 11:08:46 AM

Post# of 647234
(ARDS) $1.03 --BIG Phase 3 data IMMINENT ...Market cap only $22 million

Top-line data from the Phase 3 clinical trial evaluating AR-301 for the treatment of VAP
expected in December of this year

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.